Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.

Abstract:

PURPOSE:Patient nonadherence to oral antineoplastic therapy is a well-recognized barrier to effective treatment. In order to identify patients who may need additional support to become adherent, it is important to have a useful tool that takes into account all the parameters of adherence to prescription. The aim of this prospective study was to evaluate adherence of oral antineoplastic agents and to investigate two calculation methods of adherence score. PATIENTS AND METHODS:Twenty-nine cancer patients were enrolled in this study. Fourteen were treated by capecitabine and 15 patients by aromatase inhibitors. Adherence was measured using a medication event monitoring system and adherence score was calculated by a usual method and a composite adherence score that takes into account missed doses and also intake interval errors (between 2 doses and between meals). RESULTS:Across the 6-month evaluation period, average adherence was 95% with the standard calculation (capecitabine group: 89%; aromatase inhibitor group: 99%) versus 83% with the composite index (capecitabine group: 62%; aromatase inhibitor group: 99%) (p = 0.030). The composite calculation permits to highlight more nonadherent patients (29.6 vs. 7.4%), particularly in the capecitabine group (73 vs. 18%, p = 0.001). We report 2 cases identified as nonadherent with composite adherence rate. CONCLUSION:The composite adherence score permits to better evaluate adherence to prescription and to identify barriers to adherence and persistence.

journal_name

Oncology

journal_title

Oncology

authors

Thivat E,Van Praagh I,Belliere A,Mouret-Reynier MA,Kwiatkowski F,Durando X,Mahammedi H,Dillies AF,Chollet P,Chevrier R

doi

10.1159/000342087

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

67-74

issue

2

eissn

0030-2414

issn

1423-0232

pii

000342087

journal_volume

84

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study.

    abstract::In patients affected with different tumours, disorders concerning clotting are frequently observed. The biological processes leading to coagulation are probably involved in the mechanisms of metastasis. We studied plasma levels of thrombin-antithrombin III complexes (TAT) in 90 patients affected with lung tumours subg...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227620

    authors: Tricerri A,Vangeli M,Errani AR,Guidi L,Canetta M,Vaccarino M,De Santis C,Ipsevich F,Salvati F,Bartoloni C

    更新日期:1996-11-01 00:00:00

  • Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

    abstract:OBJECTIVES:Our aim was to assess FDG-PET/CT as a surrogate biomarker of the pathological complete response in locally advanced rectal cancer treated with neoadjuvant chemoradiation. METHODS:T3-4 and/or N+ rectal cancer patients were treated prospectively with capecitabine-based chemoradiation and total mesorectal exci...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000345601

    authors: Bampo C,Alessi A,Fantini S,Bertarelli G,de Braud F,Bombardieri E,Valvo F,Crippa F,Di Bartolomeo M,Mariani L,Milione M,Biondani P,Avuzzi B,Chiruzzi C,Pietrantonio F

    更新日期:2013-01-01 00:00:00

  • Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates.

    abstract:PURPOSE:Breast cancer (BC) is the most frequent female carcinoma and the major cause of death in women aged 35--50 years. The total number of patients surviving BC and especially the morbidity rate of patients below the age of 55 years has increased significantly in the last several years. As a consequence, the number ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055319

    authors: Beckmann MW,Jap D,Djahansouzi S,Nestle-Krämling C,Kuschel B,Dall P,Brumm C,Bender HG

    更新日期:2001-01-01 00:00:00

  • Species-specific neoplastic progression by ultraviolet light on the skin of rats, guinea pigs, hamsters and mice.

    abstract::Repeated ultraviolet light (UV) irradiation on the skin of rats caused ulceration, scarring and epithelial tumors; 38% of the animals had ear tumors and 5% skin tumors. Guinea pigs presented minimal evidence of neoplastic transformation; only two tumors were seen while hamsters displayed localized epidermal hyperplasi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225025

    authors: Stenbäck F

    更新日期:1975-01-01 00:00:00

  • Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene.

    abstract:OBJECTIVE:The herpes simplex virus thymidine kinase (HSVtk)/ganciclovir suicide gene therapy system has been considered as one of the most promising therapeutic strategies for malignant gliomas. We have been using HSVtk gene-transduced neural stem cells (NSCtk) that possess an ability to migrate toward a tumor mass for...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000091032

    authors: Li S,Tokuyama T,Yamamoto J,Koide M,Yokota N,Namba H

    更新日期:2005-01-01 00:00:00

  • Chemotherapeutic sensitivity of human colorectal tumor xenografts.

    abstract::Studies were made of the therapeutic response of six human colorectal tumor lines serially transplanted in immunosuppressed mice. The tumors with adenomatous structure showed greater sensitivity against different cytotoxic agents than the gelatinous ones. Among the drugs, 5-FU, BCNU and MeCCNU proved to be the most ef...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225496

    authors: Kopper L,Lapis K,Hegedüs C

    更新日期:1980-01-01 00:00:00

  • The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancer.

    abstract:OBJECTIVE:The purpose of this study is to investigate whether the Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 (AKAP10) is related to the risk of colorectal cancer (CRC), clinicopathological variables and the environmental factors for the development of CRC. METHODS:Ap...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000201572

    authors: Wang MJ,Zhou ZG,Wang L,Yu YY,Zhang P,Zhang Y,Cui CF,Yang L,Li Y,Zhou B,Sun XF

    更新日期:2009-01-01 00:00:00

  • miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.

    abstract:OBJECTIVES:MicroRNA (miR)-503 is downregulated in several cancers and plays a tumor-suppressive role in carcinogenesis. However, the miR-503 expression pattern, its clinical significance and its molecular mechanism in colorectal cancer (CRC) have not been investigated. METHODS:We analyzed miR-503 expression in normal ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000444493

    authors: Noguchi T,Toiyama Y,Kitajima T,Imaoka H,Hiro J,Saigusa S,Tanaka K,Inoue Y,Mohri Y,Toden S,Kusunoki M

    更新日期:2016-01-01 00:00:00

  • A New Transcutaneous Method for Breast Cancer Detection with Dogs.

    abstract::We developed a new transcutaneous method for breast cancer detection with dogs: 2 dogs were trained to sniff skin secretion samples on compresses that had been worn overnight by women on their breast, and to recognize a breast cancer sample among 4 samples. During the test, the dogs recognized 90.3% of skin secretion ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492895

    authors: Thuleau A,Gilbert C,Bauër P,Alran S,Fourchotte V,Guillot E,Vincent-Salomon A,Kerihuel JC,Dugay J,Semetey V,Kriegel I,Fromantin I

    更新日期:2019-01-01 00:00:00

  • Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

    abstract:BACKGROUND:We retrospectively investigated the treatment outcomes of second-line treatment with pazopanib or gemcitabine/docetaxel in patients with advanced soft tissue sarcoma (STS). METHODS:Ninety-one patients who were treated with pazopanib or gemcitabine/docetaxel for advanced STS between 1995 and 2015 were analyz...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492597

    authors: Kim JH,Park HS,Heo SJ,Kim SK,Han JW,Shin KH,Kim SH,Hur H,Kim KS,Choi YD,Kim S,Lee YH,Suh JS,Ahn JB,Chung HC,Noh SH,Rha SY,Kim HS

    更新日期:2019-01-01 00:00:00

  • Value of serum neuron-specific enolase in nonsmall cell lung cancer.

    abstract::To assess the prognostic value of pretreatment serum neuron-specific enolase (NSE) in nonsmall cell lung cancer (NSCLC), levels were measured in 84 NSCLC patients, 40 healthy controls, and 20 patients with benign pulmonary diseases. NSE concentration was higher in NSCLC (11.7 +/- 10.8 ng/ml) (mean +/- SD; median = 9.7...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227163

    authors: Diez M,Torres A,Ortega L,Maestro M,Hernando F,Gomez A,Picardo A,Granell J,Balibrea JL

    更新日期:1993-03-01 00:00:00

  • Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells.

    abstract::We examined the effects of cycloheximide on the amount of chromatin-bound and -unbound PCNA subpopulations in HeLa cells. The chromatin-bound PCNA content decreased rapidly in the presence of cycloheximide, whereas the reduction of the total amount of PCNA was minimal even 24 h after the treatment with cycloheximide. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227500

    authors: Sasaki K,Kurose A,Uesugi N,Kato A

    更新日期:1995-09-01 00:00:00

  • The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma.

    abstract:OBJECTIVES:A germline BIM deletion polymorphism has been proposed to predict a poor treatment efficacy of certain kinase inhibitors. The current study aimed to explore whether the BIM deletion polymorphism predicts the treatment efficacy of sorafenib for advanced hepatocellular carcinoma (HCC). METHODS:All patients wh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000356019

    authors: Shao YY,Chang YL,Huang CY,Hsu CH,Cheng AL

    更新日期:2013-01-01 00:00:00

  • Surgical treatment and prognosis for patients with gastric cancer lesions larger than ten centimeters in size.

    abstract::In 323 of 1,620 patients with gastric cancer, the lesion was > or = 10 cm in maximum diameter. Studies were done with respect to clinicopathologic features and the prognosis. Patients with tumors > or = 10 cm were younger and women patients were more numerous compared to those with tumors < 10 cm. Tumors were more adv...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227424

    authors: Maehara Y,Oiwa H,Oda S,Sakaguchi Y,Endo K,Ohno S,Sugimachi K

    更新日期:1995-01-01 00:00:00

  • Clinical experience with hyperthermia in conjunction with radiation therapy.

    abstract::The authors have reviewed the medical records of 421 sessions of hyperthermia treatments in 73 patients treated between 1987 and 1992 at the University Heights Cancer Center and the Indiana University Medical Center in Indianapolis, Ind. Temperatures attained during the course of therapy on each patient have been aver...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227209

    authors: Shidnia H,Hornback N,Ford G,Shen RN

    更新日期:1993-09-01 00:00:00

  • Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model.

    abstract::2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant food-derived mutagenic/carcinogenic heterocyclic amine (HCA), has attracted particular attention as a probable human colon carcinogen. Some studies have shown that PhIP administered in the post-initiation phase is able to enhance rat colon carci...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000127423

    authors: Doi K,Hagihara A,Wei M,Yunoki T,Fukushima S,Wanibuchi H

    更新日期:2007-01-01 00:00:00

  • Symptoms and causation of the planarian disease related to cancer.

    abstract::The disease provoked by injections of water and other harmless liquids or wounds without tissue loss, is characterized by the regression of certain organs, opening in the epidermis, pigmentary anomalies and malignant tumors. The very few worms which recover spontaneously, regenerate the eliminated parts or develop sup...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225055

    authors: Chandebois R

    更新日期:1975-01-01 00:00:00

  • Malignant fibrous histiocytoma of the spleen and chronic myelogenous leukemia. A case report.

    abstract::We report a rare case of a patient with an intrasplenic malignant fibrous histiocytoma (MFH) and chronic myelogenous leukemia. The neoplasms were synchronous in their onset and evolution. The peculiarity of the primary site of the MFH, the genetic implications of multiple primary tumors in a single patient, and the co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227384

    authors: Bonilla F,Provencio M,Fernandez E,España P

    更新日期:1994-09-01 00:00:00

  • Transforming activity of DNA extracted from BKV-transformed hamster cells after passages in culture.

    abstract::Primary fetal rat fibroblasts (FRF cells) were transfected with DNA extracted from BKV-transformed hamster kidney cells at low passage after transformation (HKBKlp cells) and at high passage after transformation (HKBKhp cells). Two transformed rat cell lines were obtained, FRF-DNA-HKBKlp cells and FRF-DNA-HKBKhp cells...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226404

    authors: Possati L,Collesi A,Rosciani C,Rubini C

    更新日期:1986-01-01 00:00:00

  • Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.

    abstract:BACKGROUND:Gemcitabine monotherapy is the cornerstone of the treatment of patients suffering from advanced pancreatic cancer (PC). For a few years, new chemotherapeutic agents and combinations have been under validation. The use of such treatment makes it necessary to determine factors that could predict survival time....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000120627

    authors: Maréchal R,Demols A,Gay F,De Maertelaere V,Arvanitaki M,Hendlisz A,Van Laethem JL

    更新日期:2007-01-01 00:00:00

  • Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy.

    abstract::While central ports are located at the chest, peripheral ports (PP) are inserted at the patients' forearms. Two new PPs (Healthport miniMax((R)) and Bard Titan Low Profile Port) and two well-established types (Port-A-Cath((R)) P.A.S. Port and PeriPort(TM) peripheral access system) were tested. 125 patients were given ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012059

    authors: Lersch C,Eckel F,Sader R,Paschalidis M,Zeilhofer F,Schulte-Frohlinde E,Theiss W

    更新日期:1999-11-01 00:00:00

  • Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.

    abstract::Expression of ras p21 in human gastric cancers, benign lesions and normal tissues was immunohistochemically evaluated by the avidin-biotin peroxidase complex (ABC) method with anti-ras p21 monoclonal antibody rp-28. Positive p21 immunoreactivity was shown in 23 (77%) of 30 gastric cancers, in 13 (48%) of 27 benign les...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226728

    authors: Nakajima K,Kuzumaki N,Oda A,Kobayashi H,Katoh H,Tanabe T

    更新日期:1989-01-01 00:00:00

  • Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

    abstract::Capecitabine is converted to 5-fluorouracil by thymidine phosphorylase, and mitomycin C is capable of upregulating the expression of thymidine phosphorylase suggesting a synergistic effect. Fifty-three patients (median age 62 years) with anthracycline- and taxane-resistant, metastatic breast cancer received mitomycin ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000096250

    authors: Massacesi C,La Cesa A,Marcucci F,Pilone A,Rocchi MB,Zepponi L,Santini D,Tonini G,Burattini L

    更新日期:2006-01-01 00:00:00

  • Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update.

    abstract::In the 2010 version of the Japan Society of Hepatology (JSH) consensus-based treatment algorithm for the management of hepatocellular carcinoma (HCC), transarterial chemoembolization (TACE) failure/refractoriness was defined assuming the use of superselective lipiodol TACE, which has been widely used worldwide and par...

    journal_title:Oncology

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1159/000368142

    authors: Kudo M,Matsui O,Izumi N,Kadoya M,Okusaka T,Miyayama S,Yamakado K,Tsuchiya K,Ueshima K,Hiraoka A,Ikeda M,Ogasawara S,Yamashita T,Minami T,Liver Cancer Study Group of Japan.

    更新日期:2014-01-01 00:00:00

  • Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinoma.

    abstract::Twenty-seven patients with advanced measurable colorectal carcinoma were treated with a combination protocol consisting of folinic acid (FA) 200 mg/m2 i.v. bolus followed by 5-fluorouracil (5-FU) 550 mg/m2, and cisplatin (CIS) 20 mg/m2 each administered as a 2-hour i.v. infusion. Treatment was given on 4 consecutive d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226719

    authors: Scheithauer W,Depisch D,Schiessel R,Ludwig H

    更新日期:1989-01-01 00:00:00

  • Modern Information Technology for Cancer Research: What's in IT for Me? An Overview of Technologies and Approaches.

    abstract::Information technology (IT) can enhance or change many scenarios in cancer research for the better. In this paper, we introduce several examples, starting with clinical data reuse and collaboration including data sharing in research networks. Key challenges are semantic interoperability and data access (including data...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000493638

    authors: Ahlbrandt J,Lablans M,Glocker K,Stahl-Toyota S,Maier-Hein K,Maier-Hein L,Ückert F

    更新日期:2020-01-01 00:00:00

  • Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

    abstract:OBJECTIVES:18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is useful for differentiating benign from malignant lesions, evaluating tumor stage, monitoring the response to therapy and detecting tumor recurrence in a variety of malignancies. Nevertheless, its use in patients with hepatocellular carcinoma (H...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000111715

    authors: Yoon KT,Kim JK,Kim DY,Ahn SH,Lee JD,Yun M,Rha SY,Chon CY,Han KH

    更新日期:2007-01-01 00:00:00

  • Synchronous Hodgkin's disease and gastric adenocarcinoma.

    abstract:BACKGROUND:Adenocarcinoma is the most frequent pathological type of stomach cancer. Hodgkin's lymphoma is a lymphoproliferative disease arising from lymphoid tissue which is characterized by Reed-Sternberg cells. Synchronous occurrence of these two malignancies has not been reported in the English literature so far. C...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000136799

    authors: Comez G,Pehlivan Y,Kalender ME,Sevinc A,Sari I,Camci C

    更新日期:2007-01-01 00:00:00

  • Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.

    abstract:OBJECTIVE:Esophagogastric cancer occurs more frequently in older patients, but these are underrepresented in clinical studies establishing the current treatment standards for perioperative chemotherapy in locally advanced disease. This leads to uncertainty regarding the treatment of older patients with potentially toxi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000458531

    authors: Haag GM,Byl A,Jäger D,Berger AK

    更新日期:2017-01-01 00:00:00

  • Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.

    abstract::A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP. In remission he developed coeliac disease, controlled by dietary measures, but 26 months after the end of chemotherapy a severe dyspeptic syndrome appeared; endoscopy and barium meal suggested the presence of a ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226345

    authors: Eridani S,Singh AK

    更新日期:1986-01-01 00:00:00